A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Launched by ADDPHARMA INC. · Apr 10, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new drug called PA-111 to understand how it works in the body and how safe it is for healthy people. Researchers are looking to compare its characteristics with another version called PA-111A. If you're healthy, at least 19 years old, and have a body weight of 50 kg or more (or 45 kg for women), you might be eligible to participate. They’re currently recruiting participants, so this is a great opportunity for those who meet the criteria.

If you decide to join the study, you’ll undergo some tests to ensure you're a good fit, and you'll be closely monitored throughout the trial. It's important to know that if you've participated in another clinical trial involving a new drug in the past six months, you won't be able to take part in this one. Your safety is a priority, and the study will help researchers learn more about this treatment for mixed dyslipidemia, a condition that affects cholesterol and fat levels in the blood.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• • The Age equal to or greater than 19 in healthy volunteers at the time of screening visit
• Exclusion Criteria:
• • Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
• • Other exclusions applied